Evercore ISI Raises Marvell Price Target to $155

Analyst: Mark Lipacis 1 min read Reproduced verbatim
Rating
Outperform
Target
$155
from $133 (+17%)
Outcome
Reached
on November 5, 2026
Evercore and Marvell logos

What the analyst said

Evercore ISI analyst Mark Lipacis raised the price target on Marvell Technology (NASDAQ: MRVL) to $155.00 (from $133.00) while maintaining an Outperform rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

MRVL trades at $134. The 24 analysts who set a target in the last 3 months range from $175 to $433, with a median of $300. This $155 target is 48% below the median, the lowest on the Street.

Since the note MRVL has moved −21% (from $169). 12-month window: day 170 of 365, closes on May 19, 2027.

Track record

This call✓ Target reached on November 5, 2026, 6 months after the note.

Firm track recordEvercore: 88% of its 16 targets at least a year old were reached within 12 months (#3 of 26 firms). Accuracy ranking →

Evercore on Marvell

Evercore price targets on Marvell

5 calls from March 4, 2026 to October 6, 2026. The target went from $133 to $433 (+226%). The rating stayed Buy.

Evercore targetMRVL share price
  1. October 6, 2026Target raised from $155 (+179%)Buy$433
  2. May 19, 2026 This noteKept the $155 targetBuy$155
  3. March 6, 2026Target raised from $133 (+17%)Buy$155
  4. March 5, 2026Kept the $133 targetBuy$133
  5. March 4, 2026Earliest call shownBuy$133
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.